NASDAQ:ELOS Syneron Medical (ELOS) Stock Price, News & Analysis → Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad) Free ELOS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$11.00▼$11.0050-Day Range N/A52-Week Range$6.18▼$11.43VolumeN/AAverage Volume562,777 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Syneron Medical alerts: Email Address Ad Paradigm PressAI “wealth window” is closing soon!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.I put together this personal video [HERE]… About Syneron Medical Stock (NASDAQ:ELOS)Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company's aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. The Company's products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, tattoo removal, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and laser-assisted lipolysis.Read More Ad Paradigm PressAI “wealth window” is closing soon!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.I put together this personal video [HERE]… ELOS Stock News HeadlinesMarch 13, 2024 | uk.investing.comApax Global Alpha Ltd (APAX)November 14, 2023 | morningstar.comElos Medtech AB Class B ELOS BApril 17, 2024 | Banyan Hill Publishing (Ad)Don’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.August 21, 2023 | thestreet.comSyneron Medical Stock Hits New 52-Week Low (ELOS)July 13, 2023 | wsj.comElos Medtech AB Series BJune 15, 2023 | thestreet.comSyneron Hires Finance ChiefMay 11, 2023 | marketwatch.comRadio Frequency Beauty Instrument Market 2023 Size, Share and Trends Analysis – Syneron Medical, Lumenis, Valeant Pharmaceutical InternationalJanuary 21, 2023 | cnbc.comAs of July 1, your medical debt may no longer hurt your credit score—here's whyApril 17, 2024 | Banyan Hill Publishing (Ad)Don’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.January 18, 2022 | thestreet.comSyneron Medical Stock Hits New 52-Week High (ELOS)January 7, 2022 | thestreet.comSyneron Medical (ELOS) Stock Spikes Today on Strong Fourth Quarter GuidanceSee More Headlines Receive ELOS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Syneron Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/04/2016Today4/17/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:ELOS CUSIPN/A CIK1291361 Websyneron-candela.com Phone+972-7-32442200FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesShimon Eckhouse Ph.D.Chairman of the BoardAmit MeridorChief Executive OfficerBio & Compensation - Hugo GoldmanChief Financial OfficerBio & Compensation - Erik DowellVice President-North AmericaWilliam GriffingChief Executive Officer - Syneron Candela North AmericaShlomo AlkalayChief Operating OfficerLisa A. SoderquistChief Human Resource OfficerBio & Compensation - Robert RuckExecutive Vice President, Asia PacificRobert FielitzVice President and Managing Director of Europe, Middle East and AfricaSarit Soccary Ben-YochananVice President - Business Development & StrategyMore Executives ELOS Stock Analysis - Frequently Asked Questions How were Syneron Medical's earnings last quarter? Syneron Medical Ltd (NASDAQ:ELOS) issued its earnings results on Thursday, August, 4th. The medical equipment provider reported $0.09 EPS for the quarter, beating analysts' consensus estimates of $0.06 by $0.03. The medical equipment provider earned $75 million during the quarter, compared to analyst estimates of $75.72 million. The business's revenue was up 2.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.07 earnings per share. What other stocks do shareholders of Syneron Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Syneron Medical investors own include Micron Technology (MU), Advanced Micro Devices (AMD), BIOLASE (BIOL), Cisco Systems (CSCO), Freeport-McMoRan (FCX), Gilead Sciences (GILD), Lannett (LCI), Rite Aid (RAD), Ambarella (AMBA) and Citigroup (C). This page (NASDAQ:ELOS) was last updated on 4/17/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchOptions trading has suddenly become more reliable.Eagle PublishingTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsYou won't believe what Citigroup just did to it's depositorsAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syneron Medical Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.